# Psychiatry Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Martin Luther King Jr. (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML001-SYN-TD
- Date: 1965-04-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Gloria Lindqvist-Bankole, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Requested by: Cornelius Ashby-Nwankwo, MD

## Reason for consultation

Exhaustion, broken sleep and low mood for about two months in a 36-year-old minister and civil rights leader who lives under sustained, real threat and works without rest. Please confirm the diagnosis (depression, an adjustment disorder, PTSD or an insomnia disorder), review his safety, and advise on therapy and medicine in a way that protects his privacy. **S**

## History

Dr. King, 36, is seen at the request of Dr. Ashby-Nwankwo. For about two months, after a winter of continuous campaigning and an admission for exhaustion six months ago, he has had low mood most days, loss of pleasure in reading and preaching, guilt that he cannot do more, poor concentration, fatigue and broken sleep of about five hours, with an hour to fall asleep and waking before five. His energy returns on the platform but drains afterwards. He has lived for nearly ten years with threats against his life and his family, including the bombing of his home, a stabbing that required chest surgery, jailings, and anonymous threats, one of which urged him to take his own life; he believes his calls are monitored. He is watchful in crowds and at home, but has no nightmares, flashbacks, avoidance or emotional numbing. He has never had a period of elevated mood, high energy or little need for sleep. At twelve, grieving his grandmother, he impulsively injured himself; he has not had thoughts of suicide since and has none now. He speaks calmly of the likelihood that he will be killed. His faith, his family and his congregation sustain him. He fears that a psychiatric record could be used against him and his work. **S**

## Examination

| System | Finding |
|---|---|
| Mental status | Composed, courteous and eloquent; tired; mood low, affect constricted but warm; thought logical and goal-directed; no suicidal ideation, intent or plan; no homicidal ideation; no psychotic features; cognition intact; insight and judgment good |
| General | Blood pressure 136/86, pulse 80; neck circumference 40 cm |

BP 136/86 mmHg; pulse 80 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 84.2 kg; BMI 29.1 kg/m². All vital signs are synthetic.

## Data reviewed

Dr. Ashby-Nwankwo's intake note and tests: PHQ-9 17 with item 9 scored 0, GAD-7 11, PC-PTSD-5 2, AUDIT-C 2; blood count, metabolic panel, TSH and hemoglobin A1c normal; ECG normal with QTc 412 ms. Today's PHQ-9 16 and his two-week sleep diary (about five hours a night). Mood Disorder Questionnaire today negative. Insomnia Severity Index 18; STOP-Bang 2. PHQ-9: 16. All results are synthetic.

## Assessment

1. **Major depressive disorder, single episode, moderate (DSM-5-TR)** (F32.1). He has five or more DSM-5-TR symptoms, including depressed mood and loss of interest, for more than two weeks, with impairment, so this is major depression and not an adjustment disorder, which cannot be diagnosed when the criteria for another disorder are met. Severity is moderate. There is no history of hypomania and the MDQ is negative, so an antidepressant is appropriate. Threat, surveillance, racism and overwork are causes of the episode, not personal failings, and are recorded as psychosocial factors. **S**
2. **PTSD considered**. He was exposed to traumatic events, but he has no intrusion or avoidance symptoms, and his vigilance is proportionate to a real and continuing danger. PTSD criteria are not met; PC-PTSD-5 2 agrees. Screening should be repeated, because symptoms can emerge later. **S**
3. **Suicide risk**. No current suicidal ideation, intent, plan or preparatory behavior. The impulsive act in childhood grief, the letter urging suicide, depression and insomnia raise risk; his faith, purpose, family, congregation and engagement in care are strong protective factors. His expectation of being killed is a realistic appraisal of danger, not passive suicidal ideation, and should be distinguished from it at each review. Overall risk is low; outpatient care with the safety plan is appropriate. **S**
4. **Insomnia disorder, comorbid with depression** (G47.00). Insomnia on most nights for more than three months with daytime impairment, driven by late-night work, travel and hyperarousal. Sleep apnea is unlikely. CBT for insomnia is the first-line treatment; a hypnotic is not advised. **S**
5. **Smoking cessation during depression treatment** (F17.210). Stopping smoking does not worsen depression and often improves mood. In the EAGLES trial varenicline did not significantly increase serious neuropsychiatric events in smokers with psychiatric disorders, and it was the most effective option. Starting it a few weeks after sertraline lets side effects be told apart. **S**

## Recommendations

1. Weekly cognitive behavioral therapy with behavioral activation and CBT for insomnia, with a therapist of his choosing who will work with his faith; then every two weeks once he responds, and monthly in remission.
2. Sertraline 25 mg each morning for a week, then 50 mg; tolerability check by telephone two weeks after starting; increase only if the PHQ-9 has not fallen by about eight to twelve weeks.
3. CBT for insomnia: fixed rising time, a sleep window widened as sleep improves, no work in bed, no tobacco or coffee in the evening; no hypnotic.
4. PHQ-9 at every visit; suicide risk reassessed at every visit, distinguishing expectation of being killed from a wish to die; PC-PTSD-5 again at about three months.
5. Varenicline with counseling, starting about three weeks after sertraline, with a quit date a week later and mood watched.
6. A sustainable work plan: a full day off each week, no more than two speeches a day, delegation of travel and correspondence, and a two-week break in the summer.
7. Privacy: restricted chart, documentation limited to what care requires, and secure video for follow-up.
8. Psychiatry review by video at about eight to twelve weeks, sooner if needed.

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Communication

Discussed with Dr. Ashby-Nwankwo, who saw him the same day. The diagnosis, the reasons PTSD is not diagnosed, the safety assessment and the options were explained to Dr. King, who chose therapy and sertraline and agreed to the work plan. **S**

## Follow-up

Psychiatry review by video in about eight to twelve weeks; therapy weekly. **S**

## Guideline basis

- Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019), American Psychological Association
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders, hypertension and hyperlipidemia monographs (2026), Aether Forge
- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023), United States Department of Veterans Affairs and Department of Defense
- Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016), American College of Physicians (Qaseem A, et al. Ann Intern Med 2016;165(2):125-133)
- Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline (2021), American Academy of Sleep Medicine (Edinger JD, et al. J Clin Sleep Med 2021;17(2):255-262)
- Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES) (2016), The Lancet (Anthenelli RM, et al. Lancet 2016;387(10037):2507-2520)
